|  Join

Education

Non-Invasive Prenatal Testing (NIPT)

This lecture was recorded on 5/20/2015
Speaker: Mary Norton

The main objectives of this presentation are to:
1. Explain the biology behind testing of cfDNA in maternal serum
2. Describe the technologies employed to evaluate cfDNA and risk for fetal aneuploidy
3. Discuss some of the biologic complexities of this technology and
4. Explain the differences between different aneuploidies and test outcome

Key:

Complete
Failed
Available
Locked
Webinar Recording
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Speaker: Mary Norton The main objectives of this presentation are to: 1-Explain the biology behind testing of cfDNA in maternal serum; 2-Describe the technologies employed to evaluate cfDNA and risk for fetal aneuploidy; 3-Discuss some of the biologic complexities of this technology and; 4-Explain the differences between different aneuploidies and test outcome
Satisfaction Survey
2 Questions
2 Questions Please provide feedback on your experience.